Jan. 26, 2017 - Patterns of brain responses to rewards are a significant predictor of pain symptoms--a link that is already present by adolescence--and may be influenced by gene variants affecting pain sensitivity, reports a study in PAIN®, the official publication of the International Association for the Study of Pain (IASP). The journal is published by Wolters Kluwer.
"Distributed" feedback patterns to rewards predict heightened pain sensitivity, according to the new research led by Frauke Nees, PhD, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany. The researchers write: "Our results might provide a first step early in life in identifying possible risk factors for future pain complaints."
Reward Responses and Pain Are Linked; Gene Variants May Play a Role
A group of more than 600 European adolescents were studied at two times. At ages 14-15, the teens participated in an experiment in which they could earn rewards -- in the form of M&M's candies--for performing a computer task. Functional magnetic resonance imaging (fMRI) scans were performed to examine how the brain processed these rewards. Two years later, the teens were evaluated on a commonly used pain symptom scale.
Patterns of reward processing at age 14-15 were evaluated as predictors of pain complaints at age 16-17. The study also examined the effects of two variants of the mu-opioid receptor gene (OPRM1) that have previously been linked to differences in pain processing. These genetic variants may affect not only responses to opioid drugs (such as morphine) but also the body's natural or "endogenous" opioids (such as endorphins).
The results showed that reward-related feedback responses in a brain area called the dorsal striatum at age 14-15 predicted the magnitude of pain symptoms at age 16-17. Whereas responses in another brain area called the ventral striatum have been linked to reward processes, the dorsal striatum has been implicated in planning, motor (movement) processing, and habit learning.
For one of the two OPRM1 variants studied, pain complaints were predicted by reward feedback-related responses in a more widely distributed brain area, including the ventral striatum. Teens with this genetic variant had a higher magnitude of pain responses.
Pain and rewards are considered "opponent yet interacting processes" involving partly similar brain regions. Identifying brain responses to rewards and their association with pain symptoms may help in understanding the neurological basis of pain-related behaviors and lend new insights into the brain areas involved in the critical transition from acute to chronic pain.
Within the limitations of the experimental study--limited to healthy children without any clinical pain problems -- the results suggest that "aversive" outcomes such as pain may be related to "appetitive" reward outcomes. "Distributed brain response patterns during reward processing may be significant predictors for pain complaints, partly depending on an opioidergic genetic predisposition," Dr. Nees and colleagues conclude.
In an accompanying commentary, Dr. David Borsook of Boston Children's Hospital highlights some important questions raised by the new results, including whether an individual's "opioidergic tone" is a real indicator of pain susceptibility and risk of developing chronic pain. While further studies will be needed, he writes, "The door has been opened for an intriguing process that may have a significant influence on improving our approach to evaluating and treating patients with pain."
Article: "Brain substrates of reward processing and the -opioid receptor: a pathway into pain?" (doi: 10.1097/j.pain.0000000000000720)
PAIN is IASP's official journal. Published monthly, PAIN presents original research on the nature, mechanisms, and treatment of pain. Available to IASP members as a membership benefit, this peer-reviewed journal provides a forum for the dissemination of multidisciplinary research in the basic and clinical sciences. It is cited in Current Contents and Index Medicus.
About the International Association for the Study of Pain
IASP is the leading professional organization for science, practice, and education in the field of pain. Membership is open to all professionals involved in research, diagnosis, or treatment of pain. IASP has more than 7,000 members in 133 countries, 90 national chapters, and 20 special interest groups (SIGs). IASP brings together scientists, clinicians, health-care providers, and policymakers to stimulate and support the study of pain and translate that knowledge into improved pain relief worldwide.
About Wolters Kluwer
Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer's market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.
Wolters Kluwer reported 2015 annual revenues of €4.2 billion. The group serves customers in over 180 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. For more information about our products and organization, visit http://www.